1Reid, G, Jass, J, Sebulsky, T & McCormick, JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16, 658–672.
2Saavedra, JM (2001) Clinical applications of probiotic agents. Am J Clin Nutr 73, 1147S–1151S.
3Morita, H, He, F, Kawase, M, Kubota, A, Hiramatsu, M, Kurisaki, J & Salminen, S (2006) Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol Immunol 50, 701–706.
4Olivares, M, Diaz-Ropero, MA, Gomez, N, Lara-Villoslada, F, Sierra, S, Maldonado, JA, Martin, R, Lopez-Huertas, E, Rodriguez, JM & Xaus, J (2006) Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 107, 104–111.
5Usman, & Hosono, A (2000) Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci 83, 1705–1711.
6Zhu, WM, Liu, W & Wu, DQ (2000) Isolation and characterization of a new bacteriocin from Lactobacillus gasseri KT7. J Appl Microbiol 88, 877–886.
7Kawai, Y, Saito, T, Uemura, J & Itoh, T (1997) Rapid detection method for bacteriocin and distribution of bacteriocin-producing strains in Lactobacillus acidophilus group lactic acid bacteria isolated from human feces. Biosci Biotechnol Biochem 61, 179–182.
8Fujiwara, S, Seto, Y, Kimura, A & Hashiba, H (2001) Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 90, 343–352.
9Takahashi, H, Fujita, T, Suzuki, Y & Benn, Y (2006) Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 50, 867–870.
10Sato, M, Uzu, K, Yoshida, T, Hamad, E, Kawakami, H, Matsuyama, H, Abd El-Gawad, I & Imaizumi, K (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013–1017.
11Thornton, SJ, Warburton, C & Wasan, KM (2007) Treatment with a cholesterol absorption inhibitor (FM-VP4) reduces body mass and adipose accumulation in developing and pre-obese mice. Drug Dev Ind Pharm 33, 1058–1069.
12Usman, & Hosono, A (1999) Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci 82, 243–248.
13Zucker, LM & Zucker, TF (1961) Fatty, a new mutation in the rat. J Hered 52, 275–278.
14Bray, GA (1977) Zucker fatty rat: a review. Fed Proc 36, 148–153.
15Meierfrankenfeld, B, Abelenda, M, Jauker, H, Klingenspor, M, Kershaw, EE, Chua, SC Jr, Leibel, RL & Schmidt, I (1996) Perinatal energy stores and excessive fat deposition in genetically obese (fa/fa) rats. Am J Physiol 270, E700–E708.
16Kajimoto, O, Hirata, H, Aoe, S, Takahashi, T, Yutaka, S & Tanaka, H (2002) Fermented milk containing Lactobacillus gasseri (SP strain) decreases serum cholesterol concentration in men with boundary and mild hypercholesterolemia. Jpn J Lactic Acid Bacteria 13, 114–124.
17Miyamoto-Shinohara, Y, Sukenobe, J, Imaizumi, T & Nakahara, T (2006) Survival curves for microbial species stored by freeze-drying. Cryobiology 52, 27–32.
18Anonymous (1977) Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 107, 1340–1348.
19Tomoyori, H, Kawata, Y, Higuchi, T, Ichi, I, Sato, H, Sato, M, Ikeda, I & Imaizumi, K (2004) Phytosterol oxidation products are absorbed in the intestinal lymphatics in rats but do not accelerate atherosclerosis in apolipoprotein E-deficient mice. J Nutr 134, 2738.
20Folch, J, Lees, M & Sloane Stanley, GH (1957) Simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497–509.
21Perona, JS & Ruiz-Gutierrez, V (2004) Virgin olive oil normalizes the altered triacylglycerol molecular species composition of adipose tissue in spontaneously hypertensive rats. J Agric Food Chem 52, 4227–4233.
22Lowry, OH, Rosebrough, NJ, Farr, AL & Randall, RJ (1951) Protein measurement with the Folin-phenol reagents. J Biol Chem 193, 265–275.
23Van de Kamer, JH, ten Bokkel Huinink, H & Weyers, HA (1949) Rapid method for the determination of fat in feces. J Biol Chem 177, 347–355.
24Jeejeebhoy, KN, Ahmad, S & Kozak, G (1970) Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3, 157–163.
25Grundy, SM, Ahrens, EH Jr & Miettinen, TA (1965) Quantitative isolation and gas–liquid chromatographic analysis of total fecal bile acids. J Lipid Res 6, 397–410.
26Johnson, PR, Stern, JS, Greenwood, MRC & Hirsch, J (1978) Adipose tissue hyperplasia and hyperinsulinemia in Zucker obese female rats: a developmental study. Metabolism 27, Suppl. 2, 1941–1954.
27Guo, KY, Halo, P, Leibel, RL & Zhang, Y (2004) Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 287, R112–R119.
28Lönnqvist, F, Nordfors, L, Jansson, M, Thörne, A, Schalling, M & Arner, P (1997) Leptin secretion from adipose tissue in women: relationship to plasma levels and gene expression. J Clin Invest 99, 2398–2404.
29Margetic, S, Gazzola, C, Pegg, GG & Hill, RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes 26, 1407–1433.
30Kokkinos, A, Mourouzis, I, Kyriaki, D, Pantos, C, Katsilambros, N & Cokkinos, DV (2007) Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine 32, 30–32.